Éclat Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Éclat Pharmaceuticals Ownership

Who owns Éclat Pharmaceuticals?

Éclat Pharmaceuticals is owned by Avadel Pharmaceuticals. It was acquired on March 14, 2012.

Éclat Pharmaceuticals Business Overview

Where is Éclat Pharmaceuticals headquartered?

Éclat Pharmaceuticals is headquartered in Chesterfield, Missouri.

What sector is Éclat Pharmaceuticals in?

Éclat Pharmaceuticals is a life science company.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.

Éclat Pharmaceuticals, LLC

699 Trade Center Boulevard Suite A,
Chesterfield, Missouri 63005
United States,
(636) 449-1830
www.eclatpharma.com

Éclat Pharmaceuticals, LLC is a specialty pharmaceutical company, is focused on the development, approval and commercialization of niche brands and generic products.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 206,577
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Éclat Pharmaceuticals

Missouri Companies , Life Science Companies , United States Companies , Missouri Life Science Companies , Missouri Life Science with Acquisitions , Missouri Life Science with Divestitures

Related Lists for Missouri Companies

Largest Missouri Companies , Acquisitive Missouri Companies , Recently Acquired Missouri Companies , Recently Sold Missouri Companies , Private Missouri Companies , Public Missouri Companies , Acquired Missouri Companies , PE Backed Missouri Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal